Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-8-10
pubmed:databankReference
pubmed:abstractText
Mucin 1 (MUC1) is a high molecular weight glycoprotein overexpressed on adenocarcinoma cells and is a target for immunotherapy protocols. To date, clinical trials against MUC1 have included advanced cancer patients. Herein, we report a trial using early stage breast cancer patients and injection of oxidized mannan-MUC1.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10630311, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10638706, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10653872, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10663612, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10673204, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10706970, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10741704, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10766024, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10766181, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10820781, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10856797, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10898509, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-10930667, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-11249691, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-11899091, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-12083518, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-14555509, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-14657390, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-15252201, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-16467101, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-2293561, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-2477330, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-2674949, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-3417635, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7479739, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7514493, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7547243, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7594478, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7594517, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7682431, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7690810, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-7923138, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-8393050, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-8495404, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-8757331, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-8843637, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-8869094, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-9330472, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-9368613, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-9389743, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-9490202, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-9548459, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-9551361, http://linkedlifedata.com/resource/pubmed/commentcorrection/16776849-9656453
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1465-542X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R27
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].
pubmed:affiliation
Immunology and Vaccine Laboratory, Burnet Institute at Austin, Heidelberg, Victoria, Australia. vasso@burnet.edu.au
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase III